Remark Holdings, Inc. (NASDAQ:MARK) has a beta value of 3.33 and has seen 2,640,380 shares traded in the recent trading session. The company, currently valued at $230.73 Million, closed the recent trade at $2.315 per share which meant it lost $0 on the day or 0.51% during that session. The MARK stock price is -53.78% off its 52-week high price of $3.56 and 89.2% above the 52-week low of $0.25. If we look at the company’s 10-day average daily trading volume, we find that it stood at 8.23 Million shares traded. The 3-month trading volume is 34.31 Million shares.
The consensus among analysts is that Remark Holdings, Inc. (MARK) is a Buy stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.07.
Remark Holdings, Inc. (NASDAQ:MARK) trade information
Sporting 0.43% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 30 when the MARK stock price touched $2.37-2 or saw a rise of 2.96%. Year-to-date, Remark Holdings, Inc. shares have moved 346.58%, while the 5-day performance has seen it change 0.43%. Over the past 30 days, the shares of Remark Holdings, Inc. (NASDAQ:MARK) have changed -12.88%. Short interest in the company has seen 14.43 Million shares shorted with days to cover at 0.42.
Wall Street analysts have a consensus price target for the stock at $4.25, which means that the shares’ value could jump 83.59% from current levels. The projected low price target is $4.25 while the price target rests at a high of $4.25. In that case, then, we find that the current price level is +83.59% off the targeted high while a plunge would see the stock lose 83.59% from current levels.
Remark Holdings, Inc. (MARK) estimates and forecasts
Figures show that Remark Holdings, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +375.6% over the past 6 months, with this year growth rate of -63.46%, compared to -4.9% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 66.7% and 33.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be +148.2%.
1 analysts offering their estimates for the company have set an average revenue estimate of $1.31 Million for the current quarter. 1 have an estimated revenue figure of $2.74 Million for the next quarter concluding in June 01, 2020. Year-ago sales stood $19.46 Million and $2.87 Million respectively for this quarter and the next, and analysts expect sales will grow by -93.3% for the current quarter and -4.4% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +19.5% over the past 5 years. Earnings growth for 2020 is a modest -8.9% while over the next 5 years, the company’s earnings are expected to increase by 0%.